Cancer News Releases
NIH researchers discover tissue biomarker that may indicate higher risk of aggressive breast cancer development and death
Incidence rates of some cancer types have risen in people under age 50
Annual Report to the Nation: Cancer deaths continue to decline
Combination immunotherapy shrank a variety of metastatic solid cancers
Daily physical activity, even at light intensities, linked to lower cancer risk
Gene therapy shows clinical benefit in patients with a debilitating disorder caused by HPV
In five cancer types, prevention and screening have been major contributors to saving lives
Researchers uncover new role of mutant RAS proteins in some of the deadliest cancers
NIH-funded scientists uncover clues to precancer and tumor biology
NIH clinical trial will test precision medicine treatments for myeloid cancers
New cancer diagnoses did not rebound as expected following pandemic
NIH study links neighborhood environment to prostate cancer risk in men with West African genetic ancestry
Immunotherapy after surgery helps people with high-risk bladder cancer live cancer-free longer
Immunotherapy approach shows potential in some people with metastatic solid tumors
For healthy adults, taking multivitamins daily is not associated with a lower risk of death
Combination targeted treatment produces lasting remissions in people with resistant aggressive B-cell lymphoma
Inherited genetic factors may predict the pattern of X chromosome loss in older women
NIH scientists develop AI tool to predict how cancer patients will respond to immunotherapy
Analysis identifies 50 new genomic regions associated with kidney cancer risk
NIH researchers develop AI tool with potential to more precisely match cancer drugs to patients
For childhood cancer survivors, inherited genetic factors influence risk of cancers later in life
Cancer Grand Challenges selects five new global, interdisciplinary teams to take on four challenges
NIH to address dwindling clinical trial patient enrollment with centralized staffing support
NIH launches research network to evaluate emerging cancer screening technologies
W. Kimryn Rathmell begins work as 17th director of the National Cancer Institute
NCI researchers develop approach that could help supercharge T-cell therapies against solid tumors
NIH immunotherapy pioneer Steven Rosenberg awarded nation’s highest honor for technology and innovation
Annual Report to the Nation Part 2: New cancer diagnoses fell abruptly early in the COVID-19 pandemic
NCI unveils comprehensive proteogenomic dataset to help cancer researchers unravel molecular mysteries
NIH study offers insights into how cells reverse their decision to divide
Biden-Harris Administration launches initiative to improve cancer outcomes in low-income areas
NCI’s ComboMATCH initiative will test new drug combinations guided by tumor biology
NCI study outlines opportunities to achieve President Biden’s Cancer Moonshot goal of reducing cancer death rates in the United States
Pragmatica-Lung Study, a streamlined model for future cancer clinical trials, begins enrolling patients
NCI study finds that immunotherapy substantially increases survival of people with lymphomatoid granulomatosis
Cancer Grand Challenges announces global research funding opportunity with nine new challenges
NCI clinical trial leads to atezolizumab approval for advanced alveolar soft part sarcoma
Statement from Monica M. Bertagnolli, M.D., Director, National Cancer Institute, National Institutes of Health
Annual Report to the Nation: Cancer deaths continue downward trend; modest improvements in survival for pancreatic cancer
Monica Bertagnolli begins work as 16th director of the National Cancer Institute
A healthy lifestyle may help former smokers lower their risk of death from all causes
NCI study of tea drinkers in the UK suggests health benefits from black tea
Many types of leisure time activity may lower risk of death for older adults
NCI awards $23 million to establish centers of excellence to study telehealth for cancer care
Interferon treatment may reduce severity of COVID-19 in people with certain genetic factors
COVID-19 was third leading cause of death in the United States in both 2020 and 2021
Four multinational, interdisciplinary teams selected to address major challenges in cancer
In people with HIV, treating precancerous anal lesions cuts risk of anal cancer by more than half
Cancer death rates among Black people declined over time, but remain higher than other racial and ethnic groups
Uterine cancer deaths are rising in the United States, and are highest among Black women
Norman Sharpless steps down as director of the National Cancer Institute
NCI launches program to offer molecular characterization of childhood cancers
Gene expression profile could enable rapid identification of anti-tumor immune cells for personalized immunotherapy
NCI study advances personalized immunotherapy for metastatic breast cancer
A high-fiber diet may improve the response of melanoma patients to immunotherapy
Drug combination helps children with acute promyelocytic leukemia avoid conventional chemotherapy
Ibrutinib improves survival for younger people with diffuse large B-cell lymphoma
Annual Report to the Nation Part 2: Patient economic burden of cancer care more than $21 billion in the United States in 2019
NCI study highlights pandemic’s disproportionate impact on Black, American Indian/Alaska Native, and Latino adults
NIH study illuminates origins of lung cancer in never smokers
In a common genetic disorder, blood test reveals when benign tumors turn cancerous
Annual Report to the Nation: Rapid decrease in lung cancer and melanoma deaths lead overall continued decline in cancer death rate
International study of rare childhood cancer finds genetic clues, potential for tailored therapy
International research teams explore genetic effects of Chernobyl radiation
Engineered immune cells deliver anticancer signal, prevent cancer from spreading
NCI statement on ending structural racism in biomedical research
NCI study finds that people with SARS-CoV-2 antibodies may have a low risk of future infection
Fecal microbiota transplants help patients with advanced melanoma respond to immunotherapy
Some postmenopausal women with breast cancer may forgo chemotherapy
Study of “exceptional responders” yields clues to cancer and potential treatments
NCI, NIBIB award contracts to develop innovative digital health technologies for COVID-19
NCI, Cancer Research UK launch Cancer Grand Challenges partnership to support bold new ideas for cancer research
New treatments spur sharp reduction in lung cancer mortality rate
AI dual-stain approach improved accuracy, efficiency of cervical cancer screening in NCI study
NIH scientists develop blood test to help improve liver cancer screening
Study identifies potential approach to treat severe respiratory distress in patients with COVID-19
Study confirms effective, less toxic alternative to standard treatment for adults with Burkitt lymphoma
Higher daily step count linked with lower all-cause mortality
NCI study provides genetic insights into osteosarcoma in children
NCI statement on clinical trials during COVID-19 pandemic
In NIH trial, selumetinib shrinks tumors, provides clinical benefit for children with NF1
Annual Report to the Nation: Cancer death rates continue to decline
Testing with combined biopsy method improves prostate cancer diagnosis in NCI study
© 2025 Part of DENAMICA. All rights reserved.